CERS vs J · rev $201.3M vs P/E 36, $14.40B cap
Cerus Corporation (CERS) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
J does not have a complete income-statement cache yet.
CERS currently screens at market cap $294.4M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the CERS and J stock pages for the full models.
Not investment advice.